Surterra Holdings, Inc.

Surterra Holdings, Inc. operates within the medical marijuana sector, providing various cannabis products tailored for patients seeking therapeutic relief and improved health outcomes. Founded in 2014 in Atlanta, US, Surterra Holdings, Inc. focuses on the medical marijuana industry, offering a range of cannabis products.

The company has secured a total of USD 82. 74 mn in funding across multiple rounds, with the latest being a Series D round in June 2019. Surterra has completed five deals, and its current valuation stands at USD 2,996. 51 mn.

Surterra offers a wide array of high-quality cannabis products, including premium flower, pre-rolls, edibles, vaporizers, concentrates, and topicals, all manufactured in a facility that emphasizes safety and quality. Their products are available to registered medical marijuana patients and are distributed across various markets, extending beyond Florida. Surterra's revenue model is built on direct-to-consumer sales through dispensaries and an online platform, facilitating straightforward product purchases. Customers can select various cannabis items, including premium flower and edibles, for in-store pickup or delivery.

The pricing strategy reflects the quality of the products, designed to meet patient needs while promoting customer retention through promotions and loyalty programs. In June 2019, Surterra Holdings, Inc. raised USD 82. 74 mn in Series D funding, which values the company at USD 2,996 mn post-money.

This funding will support future product launches and expansion into new geographic markets. Specific plans include targeting additional states with medical cannabis programs to broaden their customer base and enhance accessibility for patients seeking medicinal solutions.